NM_000077.5:c.47_50delTGGC
Variant names:
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000077.5(CDKN2A):c.47_50delTGGC(p.Leu16ProfsTer9) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L16L) has been classified as Benign.
Frequency
Genomes: not found (cov: 32)
Consequence
CDKN2A
NM_000077.5 frameshift
NM_000077.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.50
Publications
10 publications found
Genes affected
CDKN2A (HGNC:1787): (cyclin dependent kinase inhibitor 2A) This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]
CDKN2A Gene-Disease associations (from GenCC):
- melanoma, cutaneous malignant, susceptibility to, 2Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- melanoma-pancreatic cancer syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial atypical multiple mole melanoma syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- melanoma and neural system tumor syndromeInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Pathogenic. The variant received 18 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 151 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-21974777-GGCCA-G is Pathogenic according to our data. Variant chr9-21974777-GGCCA-G is described in ClinVar as Pathogenic. ClinVar VariationId is 142061.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000077.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDKN2A | NM_000077.5 | MANE Select | c.47_50delTGGC | p.Leu16ProfsTer9 | frameshift | Exon 1 of 3 | NP_000068.1 | ||
| CDKN2A | NM_058195.4 | MANE Plus Clinical | c.194-3573_194-3570delTGGC | intron | N/A | NP_478102.2 | |||
| CDKN2A | NM_001195132.2 | c.47_50delTGGC | p.Leu16ProfsTer9 | frameshift | Exon 1 of 4 | NP_001182061.1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDKN2A | ENST00000304494.10 | TSL:1 MANE Select | c.47_50delTGGC | p.Leu16ProfsTer9 | frameshift | Exon 1 of 3 | ENSP00000307101.5 | ||
| CDKN2A | ENST00000498124.1 | TSL:1 | c.47_50delTGGC | p.Leu16ProfsTer9 | frameshift | Exon 1 of 4 | ENSP00000418915.1 | ||
| CDKN2A | ENST00000579755.2 | TSL:1 MANE Plus Clinical | c.194-3573_194-3570delTGGC | intron | N/A | ENSP00000462950.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
ClinVar submissions as Germline
View on ClinVar Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts